Gara Jalqabaatti › Dukkana Dhiigaa › Nebraska › Omaha
Qorannoo klinikaalii Dukkana Dhiigaa Omaha, NE keessatti
Qorannoo 10 Dukkana Dhiigaa f Omaha fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Namoota walitti qabaa jiraQorannoo ilaalaa
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · Miili 9 fagaatti
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- The University of Nebraska Medical Center, Omaha
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- University of Nebraska Medical Center, Omaha
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Nebraska Medical Center, Omaha
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Nebraska Medical Center, Omaha
Halt Aging in Survivors of Blood Cancers
Namoota walitti qabaa jira
- University of Nebraska Medical Center, Omaha
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred and Pamela Buffett Cancer Center, Omaha
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
- University of Nebraska Medical Center, Omaha
Qorannoo Dukkana Dhiigaa magaalota biroo keessatti
- Houston, TXQorannoo 46
- New York City, NYQorannoo 26
- Boston, MAQorannoo 25
- Washington, DCQorannoo 19
- Baltimore, MDQorannoo 18
- Seattle, WAQorannoo 18
- Los Angeles, CAQorannoo 17
- Durham, NCQorannoo 16
- Chicago, ILQorannoo 15
- Philadelphia, PAQorannoo 14
- Atlanta, GAQorannoo 13
- Nashville, TNQorannoo 13
Qorannoo biroo Omaha keessatti
- Kansarii ProstateQorannoo 27
- Kansara Qara'a Non-Small CellQorannoo 24
- Saree OljooQorannoo 22
- Kansarii ColorectalQorannoo 18
- Saree (Gosoota Hunda)Qorannoo 18
- Myeloma Baay’eeQorannoo 16
- Non-Hodgkin LymphomaQorannoo 14
- Kansarii OvariiQorannoo 14
- Kansarii PancreasQorannoo 14
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 13
- Cufama OnneeQorannoo 13
- Kansara MetastatikiiQorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.